Trending...
- Meijer Customer Survey Reveals Kids May be in for Biggest Christmas Surprises
- Michigan: AG Nessel Joins Coalition Pushing for Scientific, Medical Research Funding During COVID-19 Pandemic
- MSHDA Board approves grants to Habitat for Humanity of Michigan and CEDAM, supports loans for acquisition and rehabilitation of affordable rental units in rural communities
CANTON, Mich.--(BUSINESS WIRE)--TrialAssure® – a leading, global software company advancing clinical trial disclosure and data transparency – has released its latest version of ANONYMIZE for Documents, including the functionality to anonymize and redact PDF documents concurrently. Leveraging the power of the cloud for processing, this software has been shown to save as much as 80 percent of the effort involved in the redaction and anonymization process for PDFs based on flexible and reusable rule setting features – as compared to traditional manual redaction.
TrialAssure ANONYMIZE for Documents is a first-in-class document redaction and anonymization software that combines machine learning – a form of artificial intelligence (AI) - and natural language processing (NLP) to protect patient privacy by automatically finding, masking, anonymizing, or removing personal or company confidential information from unstructured text. Through a streamlined, configurable rules-based approach, ANONYMIZE for Documents is able to quickly process documents, including:
"We are seeing a dramatic increase in the need for clinical trial sponsors to complete new and retrospective anonymization of clinical documents," said Kelly Vaillant, Director of Global Transparency Strategy & Compliance, TrialAssure. "The impetus for document anonymization comes as increasing regulations from global health authorities and added pressure from advocacy groups push for the expanded utility of data for secondary research."
More on Michimich.com
Machine learning makes document transparency easier
Through machine learning and AI, TrialAssure ANONYMIZE for Documents uses NLP to extract information whenever text is transformed, and the system then feeds this data into powerful machine learning algorithms. In doing so, ANONYMIZE for Documents improves over time in identifying where and how text should be replaced.
Before finalizing changes, users are encouraged to review all suggested anonymizations within its unique user interface. In this most recent release, users are able to review, accept, and/or reject changes within the system. The system also auto-updates the rule set applied to the document based on reviewer feedback. This leads to greater efficiencies and data traceability.
"The future of clinical trials – especially as we move to a virtual or decentralized model – is dependent on the right technology to provide secure data sharing, while ensuring that the privacy of participants and company confidential information is respected," said Mohamad Zahreddine, Chief Information Officer, TrialAssure, and member of the Forbes Technology Council. "We are on a mission to ensure that the entire industry can be transparent, allowing for increased trust and improved lives, and to do that, we must start with correctly anonymizing your documents and data."
Pharmaceutical companies, universities, and clinical research organizations (CROs) that want to stay in front of global anonymization regulations, including European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI), can request a demo of ANONYMIZE for Documents at www.trialassure.com.
More on Michimich.com
About TrialAssure
TrialAssure is a leading, global clinical trial disclosure and data transparency software suite with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and informed technology and service solutions to help clinical trial sponsors meet clinical trial registration and results reporting, document and data anonymization, patient engagement, and compliance reporting goals. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was recently named Data Solution of the Year—Healthcare in the Data Breakthrough Awards. For more information, visit: www.trialassure.com or follow TrialAssure on LinkedIn.
TrialAssure ANONYMIZE for Documents is a first-in-class document redaction and anonymization software that combines machine learning – a form of artificial intelligence (AI) - and natural language processing (NLP) to protect patient privacy by automatically finding, masking, anonymizing, or removing personal or company confidential information from unstructured text. Through a streamlined, configurable rules-based approach, ANONYMIZE for Documents is able to quickly process documents, including:
- Clinical Study Reports (CSRs) and CSR amendments
- Clinical Study Protocols
- Statistical Analysis Plans (SAPs)
- Module 2-5 documents
- Patient Narratives
- Any other document formats including Adobe PDF and Microsoft Word
"We are seeing a dramatic increase in the need for clinical trial sponsors to complete new and retrospective anonymization of clinical documents," said Kelly Vaillant, Director of Global Transparency Strategy & Compliance, TrialAssure. "The impetus for document anonymization comes as increasing regulations from global health authorities and added pressure from advocacy groups push for the expanded utility of data for secondary research."
More on Michimich.com
- Michigan: EGLE awards nearly $10 million in COVID-19 wastewater surveillance grants and equipment
- Ford to Present at Credit Suisse Industrials and Goldman Sachs Global Automotive Conferences
- The Voice Season 12 Winner Chris Blue Releases Pulsating New Single,"Back 2 The Future"
- Braeden Lichti: Digital Health Trends in 2020
- Boost Your Curb Appeal with Delights Christmas Light Installation Company
Machine learning makes document transparency easier
Through machine learning and AI, TrialAssure ANONYMIZE for Documents uses NLP to extract information whenever text is transformed, and the system then feeds this data into powerful machine learning algorithms. In doing so, ANONYMIZE for Documents improves over time in identifying where and how text should be replaced.
Before finalizing changes, users are encouraged to review all suggested anonymizations within its unique user interface. In this most recent release, users are able to review, accept, and/or reject changes within the system. The system also auto-updates the rule set applied to the document based on reviewer feedback. This leads to greater efficiencies and data traceability.
"The future of clinical trials – especially as we move to a virtual or decentralized model – is dependent on the right technology to provide secure data sharing, while ensuring that the privacy of participants and company confidential information is respected," said Mohamad Zahreddine, Chief Information Officer, TrialAssure, and member of the Forbes Technology Council. "We are on a mission to ensure that the entire industry can be transparent, allowing for increased trust and improved lives, and to do that, we must start with correctly anonymizing your documents and data."
Pharmaceutical companies, universities, and clinical research organizations (CROs) that want to stay in front of global anonymization regulations, including European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI), can request a demo of ANONYMIZE for Documents at www.trialassure.com.
More on Michimich.com
- Aesthetic MdR Named Best MediSpa and Dr. Luis Macías Named Top Cosmetic Plastic Surgeon
- HexGn & Africa Islamic Economic Foundation Team up to Train 100,000 Youth in Africa for Innovation Economy
- Michigan: Be Careful: Thanksgiving is Top Day for Home Cooking Fires
- Michigan: AG Nessel Shares Best Practices for Consumers Amid Pandemic This Holiday Season
- Michigan: Demolition of blighted Iron County properties will lead to new development opportunities
About TrialAssure
TrialAssure is a leading, global clinical trial disclosure and data transparency software suite with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and informed technology and service solutions to help clinical trial sponsors meet clinical trial registration and results reporting, document and data anonymization, patient engagement, and compliance reporting goals. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was recently named Data Solution of the Year—Healthcare in the Data Breakthrough Awards. For more information, visit: www.trialassure.com or follow TrialAssure on LinkedIn.
Filed Under: Business
0 Comments
Latest on Michimich.com
- Home2 Suites by Hilton Midland East Celebrates Topping Off
- Michigan: EGLE dismisses case contesting Nestlé water withdrawal permit
- Michigan: Portage Lake Lift Bridge work begins Nov. 30
- Michigan employers recognized for successful apprenticeship programs
- Michigan teens who need adoptive homes share personal stories; November is Adoption Month, as proclaimed by Gov. Gretchen Whitmer
- Michigan: MDARD, MI Retailers Association and Meijer Urging Consumers to Shop as Normal
- Michigan: Further protecting construction, manufacturing workers, MIOSHA enhances inspection efforts
- City of Sterling Heights announces Delay in Dodge Park Ice Rink Opening
- Syxsense Announces New Vulnerability Dashboard as Demand for Securing Remote Workers Surges
- Explosive Environmental Documentary "Planet of the Humans" Hitting Apple iTunes and Amazon This Weekend
- SpartanNash Declares Quarterly Cash Dividend
- Blue Heart Records Signs Award Winning Singer/Songwriter/Pianist Veronica Lewis
- Mopec Adds International Distribution Capabilities in 14 Countries English English
- Purfresh Clean equipment deployed for virus spread risk mitigation at U.S. Army National Guard training exercises
- ELEVATE Identified as "Vanguard Leader" in Ardent Partners 2020 VMS Technology Advisor Report
- MPSC OKs Consumers Energy's $550M Mid-Michigan Pipeline upgrade to ensure safety, boost system resilience and flexibility
- Michigan Education Trust Holds Contract Prices Steady Amid COVID-19 Pandemic, Will Reopen Enrollment Dec. 1
- Michigan: 2020-108 - 2020-2021 35a(5) Additional Instructional Time Grant Application Deadline
- Stop & Shop Takes Luigi's Cannoli Pie of Bridgeport, CT Chainwide
- Meritor Announces Standard Position Agreement with Terex Advance Mixer